Home > About RD&C

WHAT RD&C STANDS FOR

RD&C Research, Development & Consulting GmbH is a privately owned company founded in March 2014. The RD&C team covers a broad range of knowhow important for pharmaceutical drug development and is ready to provide solutions for difficult impurity issues backed-up by regulatory compliant argumentation. Together with well-known partners for analytics, synthesis, bioinformatics and toxicology RD&C offers module based services tailored to the individual requirements and needs for its clients.

RD&C is certified „CONSULTING ENGINEERS FOR PHARMACY“ in Austria and is subjected to professional Rules of Conduct laid down by Austrian law. This accredited chartered engineer status warrants fitness for combining a broad technical background with an objective view, directed towards protecting the clients’ interests and ensuring superior performance at the lowest commensurate cost. Chartered engineer status ensures quality, employability and professional recognition.

Our mission

RD&C’s mission is to provide high quality and customised expertise to the life science community. To serve our customers best, we give support to analyse, determine and implement the most-timely, cost-effective and efficient strategies to steer a molecule from early discovery to preclinical and clinical development through the regulatory maze to the market. We facilitate the implementation of a strong patent portfolio through the different stages of drug discovery, development and post-approval phases of life-cycle management.

RD&C’s consulting provides strategic and scientific complement to classical contract research organizations from early discovery, preclinical development, regulatory submissions and post marketing activities.

RD&C helps you to bring about additional essentials of your discovery and development projects in the most time-efficient and cost-saving way by giving scientific, strategic and regulatory support.

RD&C supports their clients to strengthen and broaden their product portfolio and maximizes the probability of success through detailed market and competitive intelligence analysis and in-depth knowledge of the pharmaceutical environment.

RD&C can increase your chances of developing an innovative product with a sound patent protection and high market need, which will guarantee high sales and an early Return of Investment (ROI).

Among our clients are multinational and medium-sized pharmaceutical companies, biotech start-ups, contract research organizations, public private partnerships, academic and non-profit research organizations, universities, patient associations groups and regulatory institutions.

How we work

All services are provided in a highly-flexible, individualized and customer-friendly manner. In case we are not able to provide you with an optimal proposal, we do our best to support you in any other way.

Rapid evaluation of request. We always try to respond with a proposal within less than one week.

Problems are evaluated bottom-up. Proposals of best solution for each question – We focus on your objectives at any time to maximize your benefits.

We use our scientific and regulatory-based drug discovery and development network and expertise to provide a flexible environment for clear identification of questions to be solved.

Meet the RD&C team

Dr. Helmut Buschmann

is Chemist by training and has more than 20 years’ experience in drug discovery and development, guided 15 novel drug classes into clinical phases and was appointed as inventor in over 200 patents.

E-Mail h.buschmann@rdc-concepts.com

Mobile +49 151 52058926

Senior management executive >20 years international experience in drug discovery research and drug development

Identification, evaluation, and integration of pre-clinical projects and transfer to clinical phase

Expertise in CNS disorders (e.g. pain, depression, schizophrenia, Alzheimer Disease, urinary incontinence), metabolic disorders (obesity, diabetes), cancer, and antivirals.

Management of interfaces with chemistry, pharmacology, pharmacokinetics, toxicology, and clinics to create innovative first-in-class New Chemical Entities (NCEs).

Combination of various research disciplines and approaches in drug discovery research

Innovative concepts for new drug candidates entering the clinical development phase

Commitment to the commercial aspects of the R & D process and an excellent understanding of the regulatory and intellectual property impact

Download CV

Dr. Norbert Handler

is Pharmacist by training and has broad knowledge in medicinal chemistry, analytics and intellectual property management. He also holds an MBA in General Management. Since 2016 he is general authorized and certified Expert for Pharmaceutical Chemistry at the Commercial Court in Vienna.

E-Mail n.handler@rdc-concepts.com

Mobile +43 664 8293350

Serveral years experience in pharmaceutical academic research (post-doc level)

Several years experience in pharmaceutical industrial research (drug discovery and development, impurity profiling, degradation products)

Professional experience in technology transfer

General authorized and certified expert for pharmaceutical chemistry at the trade court Vienna

out-of-the-box thinking and open mind-set for realising innovative approaches

broad interdisciplinary overview for translational aspects of projects

Strong written and verbal communication and presentation skills

Strong interdisciplinary and analytical skills; highly target oriented